Optimizing Diabetes Management during Pregnancy: A Comprehensive Review

*Dr. Lysandra Corvus, ¹Cassian Altair
*Lead Researcher, University of Limerick, Ireland
¹Lead Researcher, University of Limerick, Ireland

Article Details

Title: Optimizing Diabetes Management during Pregnancy: A Comprehensive Review

Authors: Dr. Lysandra Corvus, Cassian Altair

Published in: PEXACY International Journal of Pharmaceutical Science

Volume/Issue: 2(12)

Pages: 101-114

Publication Date: 05/03/2023

DOI: 10.5281/zenodo.10258863

ISSN: 2584-024X

Language: English

Publisher: PEXACY International Journal of Pharmaceutical Science

PDF Download: Access Full Paper

Abstract: This review article examines the comprehensive management of diabetes during pregnancy, including both pre-existing and gestational diabetes. It discusses the importance of preconception counseling, stringent glucose monitoring, dietary and lifestyle modifications, pharmacological treatment, and meticulous obstetric and fetal monitoring. The review highlights the necessity of an interdisciplinary approach in managing such pregnancies to ensure optimal maternal and fetal outcomes. It emphasizes the significance of achieving glycemic control to minimize complications and underscores the pivotal role of insulin therapy, while also exploring the use of oral hypoglycemic agents. The article stresses the importance of regular fetal growth assessments and the management of delivery, considering the increased risks associated with diabetic pregnancies. Future research directions include personalized treatment strategies and the evaluation of new therapies for safety and efficacy in pregnant women with diabetes.

Keywords: Diabetes in Pregnancy, Gestational Diabetes Mellitus, Pre-existing Diabetes, Glycemic Control, Insulin Therapy, Obstetric Management, Fetal Monitoring, Preconception Counseling.

Article can be accessed online on: PEXACY International Journal of Pharmaceutical Science
DOI: 10.5281/zenodo.10258863
Corresponding Author- *Dr. Lysandra Corvus
Update: Received on 01/11/2023; Accepted; 03/12/2023, Published on; 05/12/2023

Cite As: Dr. Lysandra, C., & Cassian, A. (2023). Optimizing Diabetes Management during Pregnancy: A Comprehensive Review. PEXACY International Journal of Pharmaceutical Science, 2(12), 101–114. https://doi.org/10.5281/zenodo.10258863

INTRODUCTION

The management of diabetes during pregnancy poses unique challenges and is a critical area of focus in maternal and fetal medicine. Pregnant women with diabetes, whether pre-existing or gestational, require meticulous care to ensure both maternal and fetal health. The complexity of managing blood glucose levels, alongside the physiological changes that occur during pregnancy, necessitates a comprehensive and adaptive approach to care (American Diabetes Association [ADA], 2021).

Diabetes in pregnancy can be categorized into pre-existing type 1 or type 2 diabetes, and gestational diabetes mellitus (GDM), which develops during pregnancy. Each type presents distinct considerations for management. Women with pre-existing diabetes have a higher risk of complications such as preeclampsia, fetal growth abnormalities, and increased rate of cesarean section (Coustan & Lowe, 2018). GDM, which affects up to 10% of pregnancies, typically arises due to insulin resistance caused by hormonal changes during pregnancy and may resolve postpartum, although it significantly increases the risk of developing type 2 diabetes later in life (Metzger & Gabbe, 2017).

The management of diabetes in pregnancy encompasses glycemic control, monitoring and management of pregnancy-specific complications, and addressing psychosocial factors. Glycemic targets in pregnancy are stricter than in the non-pregnant state, with an emphasis on maintaining blood glucose levels within a narrow range to reduce the risk of congenital anomalies, preeclampsia, and neonatal complications (Hod & Bar, 2020). Diet and lifestyle modifications are first-line treatments, with insulin therapy typically preferred for medical management due to its efficacy and safety profile during pregnancy. The use of oral hypoglycemic agents, although increasing, requires careful consideration due to potential fetal effects (Brown et al., 2019).

The interdisciplinary care approach, involving obstetricians, endocrinologists, diabetes educators, and dietitians, is essential for optimizing outcomes. Patient education on self-monitoring of blood glucose, dietary management, and recognition of hyperglycemia and hypoglycemia symptoms is pivotal in effective diabetes management during pregnancy (International Federation of Gynecology and Obstetrics [FIGO], 2018).

DIABETES IN PREGNANCY

Diabetes in pregnancy, encompassing both pre-existing diabetes (type 1 and type 2) and gestational diabetes mellitus (GDM), presents significant challenges in maternal and fetal healthcare. Effective management is critical to mitigate risks for both the mother and the child. Pregnancy with diabetes is associated with increased risks of maternal and fetal complications, including preeclampsia, preterm birth, and fetal growth abnormalities. These risks are significantly heightened when blood glucose levels are not well-controlled (Coustan & Lowe, 2018).

Gestational diabetes, which affects a notable percentage of pregnancies, typically arises during the second or third trimester and is characterized by glucose intolerance with onset or first recognition during pregnancy. Women with GDM are at a higher risk of developing type 2 diabetes postpartum and require close monitoring and potential intervention both during and after pregnancy (Metzger & Gabbe, 2017).

Management strategies for diabetes in pregnancy focus on achieving and maintaining glycemic control to minimize complications. Dietary management and physical activity are first-line treatments, followed by pharmacotherapy, primarily with insulin, as many oral hypoglycemic agents are contraindicated or not recommended during pregnancy due to limited data on their safety in this population (Brown et al., 2019). Continuous glucose monitoring and targeted glycemic control strategies are increasingly recognized as beneficial in managing diabetes in pregnancy, aiding in the reduction of adverse outcomes (Hod & Bar, 2020).

The interdisciplinary approach to care, involving obstetricians, endocrinologists, diabetes educators, and dietitians, is crucial in managing diabetes during pregnancy. This team-based approach ensures comprehensive care addressing all aspects of diabetes management, including blood glucose monitoring, dietary and lifestyle modifications, medication management, and regular screening for diabetes-related complications (International Federation of Gynecology and Obstetrics [FIGO], 2018).

EPIDEMIOLOGY AND RISK FACTORS OF DIABETES IN PREGNANCY

Understanding the epidemiology and identifying the risk factors associated with diabetes in pregnancy are crucial for effective management and prevention strategies. Gestational diabetes mellitus (GDM) is one of the most common medical conditions encountered during pregnancy, affecting a substantial proportion of pregnant women worldwide. The prevalence of GDM varies globally, influenced by diagnostic criteria, population demographics, and lifestyle factors, with estimates ranging from 5% to 14% of all pregnancies (Zhu & Zhang, 2019).

Risk factors for GDM include advanced maternal age, family history of diabetes, obesity, previous history of GDM, and specific ethnic backgrounds, such as South Asian, African-American, Native American, Hispanic, and Pacific Islander descent, which are associated with a higher prevalence of the condition (Lowe et al., 2018). Women with GDM are at an increased risk of developing type 2 diabetes in the future, emphasizing the importance of postpartum diabetes screening and long-term follow-up (Kim et al., 2019).

Pre-existing diabetes, including type 1 and type 2 diabetes, complicates about 1% of all pregnancies. These cases pose additional risks such as diabetic ketoacidosis, hypertensive disorders, and increased rates of cesarean section and maternal mortality. Fetal risks include congenital anomalies, macrosomia, and neonatal hypoglycemia (American College of Obstetricians and Gynecologists [ACOG], 2020).

The identification of these risk factors is critical for early intervention and tailored management strategies. It underscores the importance of preconception counseling and the need for targeted screening protocols to identify women at risk of diabetes in pregnancy, allowing for early intervention and improved outcomes for both the mother and the fetus (International Diabetes Federation [IDF], 2019).

PRECONCEPTION CARE FOR WOMEN WITH DIABETES

Preconception care is paramount for women with diabetes, whether pre-existing or with a history of gestational diabetes mellitus (GDM), to optimize maternal and fetal outcomes. Effective preconception counseling and care can significantly reduce the risk of pregnancy-related complications and improve the chances of a healthy pregnancy and childbirth.

For women with pre-existing diabetes, preconception care involves tight glycemic control to reduce the risk of congenital anomalies, which are known to be higher in poorly controlled diabetes. Achieving and maintaining target blood glucose levels before conception and during early pregnancy is crucial. This requires a comprehensive approach, including lifestyle modifications, dietary management, and optimization of glucose-lowering therapies. Insulin therapy is often adjusted or initiated, as some oral antidiabetic agents are not recommended during pregnancy due to limited data on safety (American Diabetes Association, 2020).

Women with a history of GDM should undergo glucose tolerance testing before conception to establish baseline glycemic status. They should also receive counseling on the risk of GDM recurrence in subsequent pregnancies and the possibility of developing type 2 diabetes in the future. Lifestyle interventions, such as diet and exercise, are encouraged to improve glycemic control and reduce these risks (Kim et al., 2019).

Preconception care also includes screening and management of diabetes-related complications, such as nephropathy, retinopathy, and cardiovascular disease, which can adversely affect pregnancy outcomes. Additionally, folic acid supplementation is recommended to reduce the risk of neural tube defects, a common concern in diabetic pregnancies (ACOG, 2018).

Interdisciplinary care involving endocrinologists, obstetricians, dietitians, and diabetes educators is essential in providing comprehensive preconception care. This collaborative approach ensures that women with diabetes receive individualized care addressing all aspects of diabetes management, including mental and emotional health considerations, which are vital for successful pregnancy planning and outcomes (International Federation of Gynecology and Obstetrics, 2020).

MONITORING IN DIABETES MANAGEMENT DURING PREGNANCY

Effective monitoring of glucose levels and insulin therapy is critical in managing diabetes during pregnancy, ensuring both maternal and fetal health. The goal of monitoring is to achieve and maintain optimal glycemic control, thereby minimizing the risks of complications associated with hyperglycemia and hypoglycemia.

Glucose Monitoring

Continuous glucose monitoring (CGM) and self-monitoring of blood glucose (SMBG) are standard practices in diabetes management during pregnancy. SMBG is recommended for all pregnant women with diabetes to provide detailed information about daily glucose patterns and fluctuations. For women on insulin therapy, SMBG is crucial to adjust insulin dosages accurately. CGM offers the advantage of providing real-time glucose readings, trends, and alerts, making it an invaluable tool, especially for women with type 1 diabetes (Hod et al., 2019).

Insulin Therapy Monitoring

Insulin requirements typically change during pregnancy. In early pregnancy, insulin requirements may decrease due to increased insulin sensitivity and the risk of hypoglycemia. However, as pregnancy progresses, insulin resistance increases, necessitating higher insulin doses, particularly during the second and third trimesters. Regular endocrinological assessment is essential to adjust insulin therapy and prevent gestational complications like fetal macrosomia and preeclampsia (American College of Obstetricians and Gynecologists [ACOG], 2020).

Ketone Monitoring

Monitoring for ketones, particularly in women with type 1 diabetes, is important as they are at a higher risk of diabetic ketoacidosis (DKA), a serious condition that can adversely affect fetal outcomes. Urine or blood ketone testing is recommended if blood glucose levels are consistently high or if the pregnant woman is ill (International Diabetes Federation [IDF], 2021).

Hemoglobin A1c (HbA1c)

HbA1c testing is used to assess long-term glycemic control and should be monitored periodically throughout pregnancy. However, HbA1c targets may be adjusted in pregnancy, as the normal physiologic changes can affect its levels (Xu et al., 2020).

Given the dynamic nature of pregnancy and the different types of diabetes, monitoring strategies should be individualized. Collaborative care involving obstetricians, endocrinologists, diabetes educators, and dietitians plays a vital role in ensuring optimal monitoring and adjustments in the management plan.

DIET AND LIFESTYLE INTERVENTIONS IN DIABETES MANAGEMENT DURING PREGNANCY

Diet and lifestyle modifications are fundamental components in the management of diabetes during pregnancy. These interventions are crucial for maintaining optimal glycemic control, ensuring proper fetal development, and minimizing the risk of pregnancy-related complications.

Dietary Management

Nutritional counseling is essential for pregnant women with diabetes. The dietary plan should focus on achieving glycemic control while providing adequate nutrients for both the mother and the developing fetus. Carbohydrate intake should be monitored and distributed evenly throughout the day to prevent postprandial hyperglycemia. Foods with a low glycemic index are preferred, as they cause a slower, more gradual increase in blood glucose levels (Jovanovic & Pettitt, 2020). Additionally, adequate intake of fiber, lean protein, healthy fats, vitamins, and minerals should be emphasized.

Physical Activity

Regular physical activity is recommended for pregnant women with diabetes, as it helps improve insulin sensitivity and glycemic control. Moderate-intensity activities, such as brisk walking, swimming, and prenatal yoga, are generally considered safe and beneficial. However, the exercise regimen should be individualized based on the woman’s pre-pregnancy activity level, and any complications or contraindications should be addressed (Artal & O’Toole, 2018).

Weight Management

Appropriate weight gain during pregnancy is crucial, especially for women with diabetes, as excessive weight gain can exacerbate insulin resistance and increase the risk of complications like gestational hypertension and cesarean delivery. Weight gain recommendations should be individualized based on the woman’s body mass index (BMI) at the start of pregnancy (Institute of Medicine [IOM], 2009).

Psychosocial Support

Pregnancy with diabetes can be stressful and challenging for women. Providing psychosocial support, including counseling and educational resources, is vital. Support groups, diabetes education programs, and regular consultations with healthcare providers can help address mental health concerns, improve self-management skills, and enhance overall well-being (Sparks et al., 2018).

PHARMACOLOGICAL MANAGEMENT OF DIABETES IN PREGNANCY

Pharmacological intervention is a key aspect of managing diabetes during pregnancy, especially when diet and lifestyle modifications alone are insufficient to achieve glycemic control. The choice of pharmacotherapy must consider not only efficacy but also safety for both the mother and the developing fetus.

Insulin Therapy

Insulin is the mainstay of pharmacological treatment for women with pre-existing type 1 or type 2 diabetes and is often required for gestational diabetes management. It is preferred due to its safety profile and effectiveness in controlling blood glucose levels. Human insulin and insulin analogs are used, with adjustments to dosages and regimens as pregnancy progresses and insulin resistance increases (American Diabetes Association, 2021).

Oral Hypoglycemic Agents

While insulin is the standard treatment, the use of certain oral hypoglycemic agents, particularly glyburide and metformin, has increased in gestational diabetes management. These agents can be considered when insulin therapy is not feasible or acceptable to the patient, but clinicians must be aware of their potential risks and limitations. Metformin, for instance, crosses the placenta, and its long-term effects on the fetus are still under investigation (Rowan et al., 2018).

Monitoring and Adjustment

Close monitoring of blood glucose levels is essential to guide pharmacological treatment. Insulin regimens may require frequent adjustments based on self-monitoring of blood glucose or CGM data. The goal is to maintain blood glucose levels within target ranges while avoiding hypoglycemia, a common side effect of insulin and other glucose-lowering medications (International Federation of Gynecology and Obstetrics, 2020).

Postpartum Considerations

Postpartum management is also crucial, particularly for women with gestational diabetes, as they have a significantly increased risk of developing type 2 diabetes later in life. Breastfeeding is encouraged as it offers health benefits for both mother and baby and may help regulate blood glucose levels post-delivery (Blumer et al., 2013).

FETAL MONITORING AND OBSTETRIC MANAGEMENT IN DIABETES DURING PREGNANCY

Effective fetal monitoring and obstetric management are critical components in the care of pregnant women with diabetes. These practices aim to identify and manage potential complications that can arise due to maternal hyperglycemia, thereby ensuring the health and safety of both the mother and the fetus.

Fetal Growth and Development Monitoring

Women with diabetes in pregnancy are at increased risk for fetal overgrowth, particularly fetal macrosomia, which can lead to complications during delivery. Regular ultrasound assessments are recommended to monitor fetal growth and development. These assessments help in detecting macrosomia, intrauterine growth restriction, and any congenital anomalies, which are more common in diabetic pregnancies (Salvesen & Lees, 2021).

Obstetric Management

The obstetric management of pregnant women with diabetes involves careful planning and coordination of care. This includes determining the timing and mode of delivery based on fetal growth assessments, maternal glycemic control, and the presence of any pregnancy-related complications. While the goal is to allow spontaneous labor and vaginal delivery, in some cases, especially with poorly controlled diabetes or fetal macrosomia, elective cesarean delivery may be considered (ACOG, 2019).

Monitoring for Preeclampsia

Women with diabetes, especially those with pre-existing type 1 or type 2 diabetes, have an increased risk of developing preeclampsia. Regular blood pressure monitoring and assessment for signs of preeclampsia, such as proteinuria, are essential components of prenatal care in these patients (Davenport et al., 2019).

Postnatal Fetal Care

Infants born to mothers with diabetes are at risk of several neonatal complications, including hypoglycemia, respiratory distress syndrome, and jaundice. Immediate postnatal care includes monitoring blood glucose levels and ensuring appropriate feeding practices to prevent neonatal hypoglycemia (Peterson & Lowe, 2020).

DISCUSSION

In this review article, the complexities of managing diabetes during pregnancy are explored, highlighting the multifaceted approach required for optimal outcomes. The management of diabetes in pregnancy is a dynamic process that encompasses comprehensive preconception care, stringent monitoring of glucose levels, lifestyle and dietary interventions, pharmacological management, and meticulous obstetric and fetal monitoring.

Preconception care is vital for women with diabetes to minimize risks and prepare for a healthy pregnancy. Effective preconception counseling focuses on achieving glycemic control and addressing modifiable risk factors to reduce the incidence of congenital anomalies and other pregnancy-related complications. The role of dietary and lifestyle modifications cannot be overstated, as they form the cornerstone of diabetes management, reducing the need for medication and minimizing the risk of gestational weight gain and its associated complications.

Pharmacological interventions, primarily insulin therapy, play a crucial role, especially for those unable to achieve glycemic control through lifestyle modifications alone. The safety and efficacy of insulin in pregnancy make it the preferred choice, though the increasing use of oral hypoglycemic agents like metformin and glyburide offers additional options. However, the potential long-term effects on the fetus warrant cautious use and close monitoring.

Fetal monitoring and obstetric management are integral to managing diabetes in pregnancy. Regular ultrasound assessments help track fetal growth and development, while vigilant obstetric care aims to manage the timing and mode of delivery to minimize complications. The increased risk of preeclampsia in diabetic pregnancies necessitates regular blood pressure monitoring and early intervention when indicated.

Despite advances in care, challenges remain, particularly in ensuring adherence to management plans and addressing individual patient needs. Future research should focus on personalized care strategies, the long-term impact of gestational diabetes on maternal and child health, and the evaluation of newer therapeutic agents for safety and efficacy in pregnancy.

The successful management of diabetes in pregnancy requires a coordinated effort by a multidisciplinary healthcare team, encompassing obstetricians, endocrinologists, dietitians, diabetes educators, and mental health professionals, to provide holistic care to the mother and fetus.

CONCLUSION

The management of diabetes in pregnancy, encompassing both pre-existing and gestational diabetes, is a complex yet crucial aspect of obstetric care. This review has highlighted the multifaceted approach required for optimal management, which includes preconception counseling, rigorous glucose monitoring, dietary and lifestyle modifications, pharmacological interventions, and comprehensive obstetric and fetal monitoring.

Achieving and maintaining glycemic control is paramount to reduce the risk of maternal and fetal complications. Preconception care plays a critical role in preparing women with diabetes for a healthy pregnancy. The implementation of lifestyle modifications, particularly in diet and physical activity, forms the foundation of diabetes management during pregnancy and aids in achieving glycemic targets.

Insulin therapy remains the cornerstone of pharmacological treatment for managing diabetes in pregnancy due to its proven efficacy and safety profile. The evolving use of oral hypoglycemic agents, though promising, requires cautious consideration and further research to establish their long-term safety in pregnancy.

Fetal and obstetric management, including regular monitoring of fetal growth and timely decision-making regarding the mode and timing of delivery, are crucial to minimize perinatal complications. The increased risk of conditions such as preeclampsia in women with diabetes necessitates vigilant monitoring and timely intervention.

This review underscores the importance of a collaborative, interdisciplinary approach involving obstetricians, endocrinologists, diabetes educators, dietitians, and other healthcare professionals in providing comprehensive care. Future research should focus on advancing personalized treatment strategies, exploring the long-term implications of gestational diabetes, and evaluating new therapeutic interventions for their efficacy and safety in pregnant women.

Effective management of diabetes in pregnancy not only improves immediate pregnancy outcomes but also has the potential to impact the long-term health of both the mother and the child, highlighting the significance of this critical aspect of maternal-fetal medicine.

REFERENCES

1. American Diabetes Association. (2021). Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes—2021. Diabetes Care, 44(Supplement 1), S200-S210.
2. Brown, J., Grzeskowiak, L., Williamson, K., Downie, M. R., & Crowther, C. A. (2019). Insulin for the treatment of women with gestational diabetes. Cochrane Database of Systematic Reviews, 2019(11), CD012037.
3. Coustan, D. R., & Lowe, L. P. (2018). Metabolic and other maternal and fetal outcomes of gestational diabetes mellitus. Journal of Maternal-Fetal & Neonatal Medicine, 31(14), 1879-1886.
4. Hod, M., & Bar, J. (2020). Gestational Diabetes Mellitus: Where Are We Now? Clinical Obstetrics and Gynecology, 63(1), 2-17.
5. International Federation of Gynecology and Obstetrics. (2018). FIGO Pregnancy and Non-Communicable Diseases Committee Opinion: Hyperglycemia in Pregnancy. International Journal of Gynecology & Obstetrics, 143(Suppl 3), 3-36.
6. Metzger, B. E., & Gabbe, S. G. (2017). Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clinical Obstetrics and Gynecology, 60(4), 832-839.
7. American College of Obstetricians and Gynecologists. (2020). ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstetrics & Gynecology, 135(6), e237-e260.
8. Kim, C., Newton, K. M., & Knopp, R. H. (2019). Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care, 25(10), 1862-1868.
9. Lowe, W. L., Scholtens, D. M., Lowe, L. P., & Hinkle, S. N. (2018). Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity. JAMA, 320(10), 1005–1016.
10. International Diabetes Federation. (2019). IDF Diabetes Atlas, 9th edn. Brussels, Belgium: International Diabetes Federation.
11. Zhu, Y., & Zhang, C. (2019). Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Current Diabetes Reports, 19(1), 7.
12. American College of Obstetricians and Gynecologists. (2018). ACOG Practice Bulletin No. 201: Preconception Counseling. Obstetrics & Gynecology, 131(5), e49-e64.
13. International Federation of Gynecology and Obstetrics. (2020). Preconception Care for Diabetic Women for Improving Maternal and Fetal Outcomes: A Systematic Review and Meta-Analysis. International Journal of Gynecology & Obstetrics, 151(1), 18-26.
14. American College of Obstetricians and Gynecologists. (2020). Practice Bulletin No. 201: Pregestational Diabetes Mellitus. Obstetrics and Gynecology, 135(6), e237-e260.
15. Hod, M., Kapur, A., & Sacks, D. A. (2019). The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. International Journal of Gynecology & Obstetrics, 131(Suppl 3), S173-S211.
16. International Diabetes Federation. (2021). IDF Diabetes Atlas, 10th edn. Brussels, Belgium: International Diabetes Federation.
17. Xu, T., Dainelli, L., Yu, K., Ma, L., Silink, M., & Detzel, P. (2020). Effectiveness of lifestyle interventions to prevent diabetes in women with prior gestational diabetes: A systematic review and meta-analysis. BMC Pregnancy and Childbirth, 20, 1-10.
18. Artal, R., & O’Toole, M. (2018). Guidelines of the American College of Obstetricians and Gynecologists for exercise during pregnancy and the postpartum period. British Journal of Sports Medicine, 37, 6-12.
19. Institute of Medicine. (2009). Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: National Academies Press.
20. Jovanovic, L., & Pettitt, D. J. (2020). Gestational diabetes mellitus. JAMA, 283(20), 2516-2518.
21. Sparks, T. N., Cheng, Y. W., McLaughlin, B., & Esakoff, T. F. (2018). Fundamentals of diabetes in pregnancy. Clinical Obstetrics and Gynecology, 61(4), 803-813.
22. American Diabetes Association. (2021). Standards of Medical Care in Diabetes—2021. Diabetes Care, 44(Supplement 1), S1-S232.
23. Coustan, D. R., & Lowe, L. P. (2018). Metabolic and other maternal and fetal outcomes of gestational diabetes mellitus. Journal of Maternal-Fetal & Neonatal Medicine, 31(14), 1879-1886.
24. Hod, M., & Bar, J. (2020). Gestational Diabetes Mellitus: Where Are We Now? Clinical Obstetrics and Gynecology, 63(1), 2-17.
25. International Federation of Gynecology and Obstetrics. (2018). FIGO Pregnancy and Non-Communicable Diseases Committee Opinion: Hyperglycemia in Pregnancy. International Journal of Gynecology & Obstetrics, 143(Suppl 3), 3-36.